Session Datesort descending
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/RTOG 07.01): a randomized, factorial, multicentre, open-label, phase 3 study. September, 12th, 2022 09/12/2022 - 8:00am to 9:00am CDT
Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small cell lung cancer and proven mediastinal N2 involvement (Lung ART, IFCT 0503): An open-label randomized, phase 3 trial. October 3rd, 2022 10/03/2022 - 8:00am to 9:00am CDT
Ga-Dotatate PET-Based Radiation Contouring Creates More Precise Radiation Volumes for Patients with Meningioma, November, 1st, 2022 11/01/2022 - 8:00am to 9:00am CDT
Neoadjuvant Chemoradiotherapy Versus upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial. December 6, 2022 12/06/2022 - 8:00am to 9:00am CST
Human Oncology Journal Club - Planning Committee Disclosure (22-23) 02/28/2023 - 11:00pm to 11:59pm CST